ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SILVIA DELGADO

Neurology

704

$893K

56
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 27%

$1269
Average prescription price

Avg: $204

JUAN SANCHEZ MD

Neurology

2,355

$305K

315
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 27%

$130
Average prescription price

Avg: $204

MARK WERNER MD

Neurology

522

$88.4K

56
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$169
Average prescription price

Avg: $204

MARK GOLDSTEIN MD

Neurology

1,662

$165K

305
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$99
Average prescription price

Avg: $204

STUART ISAACSON MD

Neurology

3,528

$1.75M

331
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 27%

$497
Average prescription price

Avg: $204

JORGE PELAEZ MD

Neurology

2,411

$528K

251
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$219
Average prescription price

Avg: $204

LARRY HORTON MD

Neurology

2,451

$601K

359
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$245
Average prescription price

Avg: $204

JOSE CARRAU MD

Neurology

474

$75.1K

91
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$158
Average prescription price

Avg: $204

ALAMELU MURUGAPPAN M.D

Neurology

919

$151K

155
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$164
Average prescription price

Avg: $204

ANGELA SPENCER M.D.

Neurology

554

$108K

99
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 27%

$194
Average prescription price

Avg: $204

PATRICIA MYERS M.D.

Neurology

401

$46.8K

78
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$117
Average prescription price

Avg: $204

EDWIN WINGKUN MD

Neurology

1,344

$279K

175
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$207
Average prescription price

Avg: $204

RICARDO GONZALEZ MD

Neurology

1,372

$489K

239
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$357
Average prescription price

Avg: $204

DAVID SHAW MD

Neurology

242

$26.8K

42
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$111
Average prescription price

Avg: $204

SYLVIA ZUNIGA-BARBONI M.D.

Neurology

1,477

$267K

253
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 27%

$180
Average prescription price

Avg: $204

JOSE GARCIA GUERRA M.D.

Neurology

1,478

$382K

242
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$258
Average prescription price

Avg: $204

MICHELLE DOMPENCIEL M.D.

Neurology

4,102

$322K

1145
1043 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $204

KATHERINE BENCZE MD

Neurology

930

$213K

113
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$229
Average prescription price

Avg: $204

HAL PINELESS D.O.

Neurology

770

$489K

142
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 27%

$635
Average prescription price

Avg: $204

GILBERTO CRUZ M.D.

Neurology

6,651

$773K

648
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$116
Average prescription price

Avg: $204

DANIEL STEIN MD

Neurology

866

$609K

163
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$704
Average prescription price

Avg: $204

RICHARD ISAACSON M.D.

Neurology

362

$52.9K

36
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $204

APARNA WAGLE SHUKLA MD

Neurology

807

$81.5K

121
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$101
Average prescription price

Avg: $204

TIMOTHY WIERZBICKI MD

Neurology

1,538

$367K

229
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$239
Average prescription price

Avg: $204

DEBORAH HEROS MD

Neurology

563

$40.9K

74
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank